https://www.selleckchem.com/pr....oducts/nor-noha-dihy
core (P=0.39) or in opioid morphine equivalents required per hour (P=0.18). Patients who received PO methylnaltrexone after PSFI had decreased length of stay and improved bowel function. Administration of methylnaltrexone did not increase maximum self-reported FACES pain values or opioid consumption compared with controls. The use of oral methylnaltrexone after PSFI reduces postoperative constipation, which has implications for reducing hospital length of stay and overall morbidity. Level III-retrospective comparative s
Like
Comment
Share
